![Hugh Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hugh Huang worked as a Senior Director of Chemistry Manufacturing & Controls at Avalo Therapeutics, Inc. and as a VP of Chemistry Manufacturing & Controls at Galectin Therapeutics, Inc. He holds a doctorate degree from The Ohio State University and an undergraduate degree from Nanjing University.
| Sociétés | Poste | Fin |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | Corporate Officer/Principal | 01/06/2023 |
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Galectin Therapeutics, Inc.
 Galectin Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs to combat various diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
